156 related articles for article (PubMed ID: 31256280)
21. Skeletal muscle magnetic resonance imaging in Pompe disease.
Díaz-Manera J; Walter G; Straub V
Muscle Nerve; 2021 May; 63(5):640-650. PubMed ID: 33155691
[TBL] [Abstract][Full Text] [Related]
22. Are there common walking gait characteristics in patients diagnosed with late-onset Pompe disease?
Starbuck C; Reay J; Silk E; Roberts M; Hendriksz C; Jones R
Hum Mov Sci; 2021 Jun; 77():102777. PubMed ID: 33730657
[TBL] [Abstract][Full Text] [Related]
23. Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement.
Al-Hashel J; Ismail I
Case Rep Neurol; 2022; 14(1):98-103. PubMed ID: 35431876
[TBL] [Abstract][Full Text] [Related]
24. Decreased outlet angle of the superior cerebellar artery as indicator for dolichoectasia in late onset Pompe disease.
Hensel O; Schneider I; Wieprecht M; Kraya T; Zierz S
Orphanet J Rare Dis; 2018 Apr; 13(1):57. PubMed ID: 29653542
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing.
Lévesque S; Auray-Blais C; Gravel E; Boutin M; Dempsey-Nunez L; Jacques PE; Chenier S; Larue S; Rioux MF; Al-Hertani W; Nadeau A; Mathieu J; Maranda B; Désilets V; Waters PJ; Keutzer J; Austin S; Kishnani P
Orphanet J Rare Dis; 2016 Jan; 11():8. PubMed ID: 26809617
[TBL] [Abstract][Full Text] [Related]
26. The impact of antibodies in late-onset Pompe disease: a case series and literature review.
Patel TT; Banugaria SG; Case LE; Wenninger S; Schoser B; Kishnani PS
Mol Genet Metab; 2012 Jul; 106(3):301-9. PubMed ID: 22613277
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pathophysiological clues of respiratory dysfunction in late-onset Pompe disease: New insights from a comparative study by MRI and respiratory function assessment.
Gaeta M; Musumeci O; Mondello S; Ruggeri P; Montagnese F; Cucinotta M; Vinci S; Milardi D; Toscano A
Neuromuscul Disord; 2015 Nov; 25(11):852-8. PubMed ID: 26410244
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment.
Montagnese F; Barca E; Musumeci O; Mondello S; Migliorato A; Ciranni A; Rodolico C; De Filippi P; Danesino C; Toscano A
J Neurol; 2015; 262(4):968-78. PubMed ID: 25673129
[TBL] [Abstract][Full Text] [Related]
29. Novel approaches to quantify CNS involvement in children with Pompe disease.
Korlimarla A; Spiridigliozzi GA; Crisp K; Herbert M; Chen S; Malinzak M; Stefanescu M; Austin SL; Cope H; Zimmerman K; Jones H; Provenzale JM; Kishnani PS
Neurology; 2020 Aug; 95(6):e718-e732. PubMed ID: 32518148
[TBL] [Abstract][Full Text] [Related]
30. Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.
Pichiecchio A; Sacco S; De Filippi P; Caverzasi E; Ravaglia S; Bastianello S; Danesino C
J Neurol; 2017 Oct; 264(10):2110-2118. PubMed ID: 28856460
[TBL] [Abstract][Full Text] [Related]
31. The emerging phenotype of late-onset Pompe disease: A systematic literature review.
Chan J; Desai AK; Kazi ZB; Corey K; Austin S; Hobson-Webb LD; Case LE; Jones HN; Kishnani PS
Mol Genet Metab; 2017 Mar; 120(3):163-172. PubMed ID: 28185884
[TBL] [Abstract][Full Text] [Related]
32. Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD).
Garibaldi M; Sacconi S; Antonini G; Desnuelle C
J Neurol; 2017 Mar; 264(3):589-590. PubMed ID: 28120044
[No Abstract] [Full Text] [Related]
33. Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining.
Jones HN; Crisp KD; Robey RR; Case LE; Kravitz RM; Kishnani PS
Mol Genet Metab; 2016 Feb; 117(2):120-8. PubMed ID: 26381077
[TBL] [Abstract][Full Text] [Related]
34. Treatment Dilemma in Children with Late-Onset Pompe Disease.
Faraguna MC; Crescitelli V; Fornari A; Barzaghi S; Savasta S; Foiadelli T; Veraldi D; Paoletti M; Pichiecchio A; Gasperini S
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833288
[TBL] [Abstract][Full Text] [Related]
35. Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study.
Figueroa-Bonaparte S; Llauger J; Segovia S; Belmonte I; Pedrosa I; Montiel E; Montesinos P; Sánchez-González J; Alonso-Jiménez A; Gallardo E; Illa I; ; Díaz-Manera J
Sci Rep; 2018 Jul; 8(1):10898. PubMed ID: 30022036
[TBL] [Abstract][Full Text] [Related]
36. Characterization of gait in late onset Pompe disease.
McIntosh PT; Case LE; Chan JM; Austin SL; Kishnani P
Mol Genet Metab; 2015 Nov; 116(3):152-6. PubMed ID: 26372341
[TBL] [Abstract][Full Text] [Related]
37. Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease.
Ruggeri P; Lo Monaco L; Musumeci O; Tavilla G; Gaeta M; Caramori G; Toscano A
Neurol Sci; 2020 Aug; 41(8):2175-2184. PubMed ID: 32162165
[TBL] [Abstract][Full Text] [Related]
38. Qualitative interviews to improve patient-reported outcome measures in late-onset Pompe disease: the patient perspective.
Hamed A; An Haack K; Gwaltney C; Baranowski E; Stewart A; Krupnick R; Tyler M; Sparks S; Paty J
Orphanet J Rare Dis; 2021 Oct; 16(1):428. PubMed ID: 34641935
[TBL] [Abstract][Full Text] [Related]
39. Late-onset Pompe disease in a 54 year-old sportsman with an episode of syncope: a case report.
Walczak-Galezewska M; Skrypnik D; Szulinska M; Musialik K; Skrypnik K; Bogdanski P
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(16):3665-3667. PubMed ID: 28925476
[TBL] [Abstract][Full Text] [Related]
40. Bright tongue sign in Pompe disease.
Karam C
Neurology; 2016 Jan; 86(4):401. PubMed ID: 26810423
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
